Trial record 1 of 1 for:    NCT00256750
Previous Study | Return to List | Next Study

Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)

This study has been completed.
Information provided by (Responsible Party):
Bristol-Myers Squibb Identifier:
First received: November 15, 2005
Last updated: October 2, 2015
Last verified: October 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2015
  Primary Completion Date: June 2008 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: April 29, 2010